Filipa Henderson Sousa
Evolution and immunopathology of chikungunya virus informs therapeutic development
Henderson Sousa, Filipa; Ghaisani Komarudin, Amalina; Findlay-Greene, Fern; Bowolaksono, Anom; Sasmono, R. Tedjo; Stevens, Craig; Barlow, Peter G.
Authors
Amalina Ghaisani Komarudin
Dr Fern Findlay-Greene F.Findlay-Greene@napier.ac.uk
Research Technician
Anom Bowolaksono
R. Tedjo Sasmono
Dr Craig Stevens C.Stevens@napier.ac.uk
Associate Professor
Prof Peter Barlow P.Barlow@napier.ac.uk
Professor
Abstract
Chikungunya virus (CHIKV), a mosquito-borne alphavirus, is an emerging global threat identified in more than 60 countries across continents. The risk of CHIKV transmission is rising due to increased global interactions, year-round presence of mosquito vectors, and the ability of CHIKV to produce high host viral loads and undergo mutation. Although CHIKV disease is rarely fatal, it can progress to a chronic stage, during which patients experience severe debilitating arthritis that can last from several weeks to months or years. At present, there are no licensed vaccines or antiviral drugs for CHIKV disease, and treatment is primarily symptomatic. This Review provides an overview of CHIKV pathogenesis and explores the available therapeutic options and the most recent advances in novel therapeutic strategies against CHIKV infections.
Journal Article Type | Review |
---|---|
Online Publication Date | Apr 4, 2023 |
Publication Date | 2023-04 |
Deposit Date | Apr 11, 2023 |
Publicly Available Date | Jun 26, 2023 |
Journal | Disease Models & Mechanisms |
Print ISSN | 1754-8403 |
Electronic ISSN | 1754-8411 |
Publisher | Company of Biologists |
Peer Reviewed | Peer Reviewed |
Volume | 16 |
Issue | 4 |
DOI | https://doi.org/10.1242/dmm.049804 |
Keywords | Chikungunya virus, Chikungunya pathogenesis, Antiviral compounds, Vaccines, Monoclonal antibodies, Immunomodulatory drugs |
Files
Evolution and immunopathology of chikungunya virus informs therapeutic development
(1.5 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
You might also like
Antiviral host defence peptides.
(2016)
Book Chapter
Cathelicidins display conserved direct antiviral activity towards rhinovirus.
(2017)
Journal Article
Antiviral therapeutic approaches for human rhinovirus infections
(2018)
Journal Article
Inflammatory Bowel Disease Drugs: A Focus on Autophagy
(2016)
Journal Article
Downloadable Citations
About Edinburgh Napier Research Repository
Administrator e-mail: repository@napier.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search